Company / Profit Margin
Supernus Pharmaceuticals, Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-5.4%
FY2025
5-year range
-5.4% / 11.2%
FY2021-FY2025
Trend
-148.0%
vs FY2024
Sector context
#67 of 146
Health Care
What the data says
At -5.4%, Supernus Pharmaceuticals, Inc.'s profit margin ranks #67 of 146 in the Health Care sector. Profit Margin has fluctuated over the past 10 years, ranging from -11.8% in FY2016 to 132.3% in FY2019.
Based on SEC 10-K filings.
-5.4% in FY2025 with a 5-year CAGR of -29.8%.
Declined from 0.2% to -5.4% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -14.5pp
- 5-Year Change
- -29.8pp
- 10-Year Change
- -
Sector benchmark
#67 of 146 in Health CareTop 46% of 146This company -5.4% Sector average -796.3%
▼
+99.3% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 148.0% year-over-year.
- Currently 790.9pp above the Health Care sector average.
- Peak profit margin was recorded in FY2019.
- Lowest profit margin in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -5.4% | -148.0% |
| FY2024 | 11.2% | +4972.7% |
| FY2023 | 0.2% | -97.6% |
| FY2022 | 9.1% | -1.2% |
| FY2021 | 9.2% | -62.2% |
| FY2020 | 24.4% | -81.6% |
| FY2019 | 132.3% | +211.7% |
| FY2018 | 42.4% | +348.5% |
| FY2017 | 9.5% | +180.2% |
| FY2016 | -11.8% | -224.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026